Based on the metabolic effects of the GH–IGF-1 axis on the adipose tissue and the liver, different pathogenic mechanisms were suggested as a possible link between GHD and NAFLD [150,151], notably including insulin resistance, which is a shared common denominator of both diseases. This evidence concerns the gene GH1 and metabolic dysfunction-associated steatotic liver disease.